Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Genentech
Pharma
Roche burnishes breast cancer portfolio with FDA nod for Itovebi
To be marketed under the brand name Itovebi, inavolisib is a threat to Novartis’ fellow PI3K inhibitor Piqray and AstraZeneca’s AKT inhibitor Truqap.
Angus Liu
Oct 10, 2024 5:30pm
Roche's Gazyva chases new kidney disease use with phase 3 win
Sep 26, 2024 11:30am
Roche doubles down with subcutaneous FDA nod for MS star Ocrevus
Sep 13, 2024 1:50pm
Meet the winners of the 2024 Fierce Pharma Marketing Awards
Sep 12, 2024 9:00am
Genentech, ADA launch eye health equity program in D.C.
Aug 7, 2024 12:13pm
Genentech takes to TikTok to push biomarker testing message
Aug 2, 2024 7:15am
